Risk of cardiovascular and cerebrovascular events in hepatitis C patients following completion of direct-acting antiviral therapy: a retrospective cohort study

被引：8
|
作者：
Singer, A. W. [1 ]
Osinusi, A. [1 ]
Brainard, D. M. [1 ]
Chokkalingam, A. P. [1 ]
机构：
[1] Gilead Sci, Foster City, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30882-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-215
引用
收藏
页码：S282 / S283
页数：2
相关论文
共 50 条
  • [1] Risk of end stage renal disease in hepatitis C patients following completion of direct-acting antiviral therapy: a retrospective cohort study
    Singer, Amanda W.
    Osinusi, Anu O.
    Brainard, Diana M.
    Telep, Laura
    Chokkalingam, Anand P.
    [J]. HEPATOLOGY, 2017, 66 : 519A - 519A
  • [2] Risk of Incident Diabetes in Hepatitis C Patients Following Completion of Direct-Acting Antiviral Therapy
    Singer, Amanda
    Osinusi, Anu O.
    Brainard, Diana
    Telep, Laura
    Chokkalingam, Anand
    [J]. HEPATOLOGY, 2018, 68 : 350A - 350A
  • [3] Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study
    Khan, Adeel S.
    Adams, Nathaniel
    Vachharajani, Neeta
    Dageforde, LeighAnne
    Wellen, Jason
    Shenoy, Surendra
    Crippin, Jeffrey S.
    Doyle, Majella B.
    Chapman, William C.
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 75 : 84 - 90
  • [4] A commentary on "Liver transplantation for Hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study"
    Bhuvanakrishna, Thakshyanee
    Wakefield, Simon
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 76 : 62 - 63
  • [5] Therapy completion of direct-acting antivirals for hepatitis C
    Machado, Marina A. A.
    Moura, Cristiano S.
    Klein, Marina
    Carleton, Bruce
    Winthrop, Kevin
    Abrahamowicz, Michal
    Feld, Jordan
    Curtis, Jeffrey R.
    Bernatsky, Sasha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 498 - 499
  • [6] Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study
    Singer, A. W.
    Reddy, K. R.
    Telep, L. E.
    Osinusi, A. O.
    Brainard, D. M.
    Buti, M.
    Chokkalingam, A. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (09) : 1278 - 1287
  • [7] Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
    Leah L. Zullig
    Haresh L. Bhatia
    Ziad F. Gellad
    Mark Eatherly
    Rochelle Henderson
    Hayden B. Bosworth
    [J]. BMC Health Services Research, 19
  • [8] Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
    Zullig, Leah L.
    Bhatia, Haresh L.
    Gellad, Ziad F.
    Eatherly, Mark
    Henderson, Rochelle
    Bosworth, Hayden B.
    [J]. BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [9] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    [J]. Current Hepatology Reports, 2018, 17 (4) : 377 - 384
  • [10] Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
    Lee, Chang Hun
    Kim, In Hee
    [J]. GUT AND LIVER, 2021, 15 (03) : 327 - 328
12345